Published in Eur J Med Res on March 30, 2010
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (1999) 5.55
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet (2003) 4.88
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis (2001) 4.72
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS (2007) 3.25
Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology (2007) 2.39
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS (2005) 2.34
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS (2004) 2.14
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis (2003) 2.11
Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis (2006) 2.01
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS (2007) 1.92
Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol (2007) 1.77
Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients? Clin Infect Dis (2005) 1.66
HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology (2008) 1.60
Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr (2006) 1.49
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS (2006) 1.44
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut (2009) 1.43
[Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients]. Med Clin (Barc) (2009) 1.41
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS (2004) 1.25
Antiretroviral therapy-associated hyperlipidaemia in HIV disease. Curr Opin Lipidol (2001) 1.15
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther (2008) 1.12
Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. PLoS One (2009) 1.12
Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection. J Infect Dis (2005) 1.10
Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. World J Gastroenterol (2009) 0.94
Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort. J Acquir Immune Defic Syndr (2007) 0.90
Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid. AIDS Res Hum Retroviruses (2009) 0.90
Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis (2008) 0.87
Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. AIDS (2008) 0.86
Changes in liver-related hospital admissions and hospital mortality among HIV-infected patients (1998 to 2005). Enferm Infecc Microbiol Clin (2008) 0.81
Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients. J Antimicrob Chemother (2006) 0.77
Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol (1997) 3.79
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut (2009) 1.43
Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut (2005) 1.28
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials (2003) 1.18
Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol (1998) 1.17
[Conjunctival ophthalmomyiasis caused by Oestrus ovis]. Enferm Infecc Microbiol Clin (1993) 1.14
[Captopril and transaminase increase. A causal or incidental relation?]. Aten Primaria (1990) 1.08
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am J Trop Med Hyg (1999) 1.03
CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol (2000) 0.99
Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur J Clin Microbiol Infect Dis (1996) 0.98
Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy. Eur J Clin Microbiol Infect Dis (2002) 0.96
Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. J Viral Hepat (2010) 0.95
The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum. Ann Trop Med Parasitol (2002) 0.94
Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis (2003) 0.93
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis. J Antimicrob Chemother (2008) 0.92
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Med (2011) 0.92
Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis. Mol Microbiol (1994) 0.90
Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients. J Clin Microbiol (1998) 0.89
Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients. J Viral Hepat (2006) 0.86
Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin. Am J Physiol (1999) 0.86
Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. Trans R Soc Trop Med Hyg (1996) 0.86
Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis (2001) 0.85
Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis (1999) 0.85
[Erosive gastritis associated with cryptosporidium in 2 patients with AIDS]. Acta Gastroenterol Latinoam (1994) 0.85
Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy. HIV Med (2004) 0.84
Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain. Eur J Clin Microbiol Infect Dis (2001) 0.84
Leishmania spp infection in injecting drug users. Lancet (2002) 0.83
Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis. J Infect Dis (1992) 0.83
Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2005) 0.83
Bradykinin (Bk) increases cytosolic calcium in cultured rat myenteric neurons via Bk-2 type receptors coupled to mobilization of extracellular and intracellular sources of calcium: evidence that calcium influx is prostaglandin dependent. J Pharmacol Exp Ther (1994) 0.82
Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment. Eur J Clin Microbiol Infect Dis (2011) 0.82
Gastrin induces c-fos gene transcription via multiple signaling pathways. Am J Physiol (1999) 0.82
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection. AIDS (1997) 0.81
The human histamine H(2) receptor regulates c-jun and c-fos in a differential manner. Am J Physiol Cell Physiol (2000) 0.81
Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. Neuropathol Appl Neurobiol (2011) 0.80
False-positive results of leishmanin skin test due to phenol-containing diluent. Trans R Soc Trop Med Hyg (2001) 0.80
[Prevalence of serum antibodies against Bartonella ssp. in a health population from the south area of the Seville province]. Rev Clin Esp (2005) 0.79
Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine. J Hepatol (1999) 0.79
[Impact of medical approach on the presentation form of AIDS defined by clinical episodes]. Med Clin (Barc) (1998) 0.79
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV. Infection (2012) 0.78
Recognition of explosives fingerprints on objects for courier services using machine learning methods and laser-induced breakdown spectroscopy. Talanta (2013) 0.77
[Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja]. Med Clin (Barc) (2001) 0.77
Immunoglobulin V regions of a bactericidal anti-Neisseria meningitidis outer membrane protein monoclonal antibody. Scand J Immunol (1990) 0.77
Regulation and function of p38 protein kinase in isolated canine gastric parietal cells. Am J Physiol Gastrointest Liver Physiol (2000) 0.77
Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy. Clin Infect Dis (1998) 0.77
Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta2microglobulin levels. Eur J Clin Microbiol Infect Dis (2003) 0.75
HIV-1 progression in hepatitis-C-infected drug users. Lancet (2001) 0.75
CCK receptor trafficking: a novel paradigm of travel focus on "regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist". Am J Physiol (1999) 0.75
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia. Eur J Clin Microbiol Infect Dis (2015) 0.75
[Enterovulvar and enteroanal fistula in a female patient infected with the human immunodeficiency virus]. Enferm Infecc Microbiol Clin (2001) 0.75
[Seminography in the study of the sterile male]. Actas Urol Esp (1982) 0.75
Our experience in combining mechanics. Am J Orthod Dentofacial Orthop (1996) 0.75
Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype b and advanced immunosuppression. J Infect (2001) 0.75
Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection. Arch Virol (2014) 0.75
[Granulomatous pneumonitis: a clinical manifestation and atypical pathology of pneumocystosis in AIDS]. Med Clin (Barc) (1995) 0.75
[Experimental innoculation of the chick embryo using mycobacteria]. Microbiol Esp (1969) 0.75
[Kala-azar in HIV infection: the tip of the iceberg?]. Med Clin (Barc) (1996) 0.75
[The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection]. Med Clin (Barc) (1999) 0.75
[Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections]. Rev Med Univ Navarra (1989) 0.75
[Barcelona Bipolar Eating Disorder Scale (BEDS): a self-administered scale for eating disturbances in bipolar patients]. Actas Esp Psiquiatr (2004) 0.75
[Intestinal amebiasis: endoscopic evaluation of tissue destruction and contributing factors]. Arch Invest Med (Mex) (1980) 0.75
Effect of antipyretics on the length of hospital stay of pediatric patients with bacterial infections. Am J Hosp Pharm (1981) 0.75
[Antiretroviral treatment with nucleoside analogs does not decrease the viremia of the hepatitis C virus in patients with HIV-1 infection]. Med Clin (Barc) (1998) 0.75